Some patients recover quickly after Lyme disease treatment. Others continue to experience fatigue, cognitive slowing, joint pain, dizziness, or sleep disruption long after antibiotics are completed. When symptoms persist, patients are often left wondering: Why am I still sick?

Persistent Lyme disease symptoms often reflect overlapping biologic processes rather than a single cause. In clinical practice, stabilization of infection is foundational. However, ongoing autonomic and regulatory instability frequently contributes to prolonged or fluctuating symptom patterns.

Persistent Lyme disease symptoms describe this ongoing clinical phase after infection. In medical research, this pattern is often labeled post-treatment Lyme disease syndrome (PTLDS). Many clinicians and patients use the term chronic Lyme disease. This page uses “persistent Lyme disease symptoms” as a neutral umbrella term—acknowledging continued illness without presuming a single mechanism or taking sides in terminology debates.

Research definition: Researchers typically define PTLDS as symptoms lasting at least six months after recommended antibiotic therapy when no alternative diagnosis explains the clinical picture. For the research framework, see Post-Treatment Lyme Disease Syndrome (PTLDS).

Regardless of language, the clinical reality is the same: some patients continue to struggle after standard therapy and require structured reassessment—not dismissal.

Common Persistent Symptoms

Patients with persistent Lyme disease symptoms frequently report:

• Profound fatigue
• Brain fog and slowed processing
• Migratory joint or muscle pain
• Neuropathy or tingling sensations
• Dizziness or orthostatic intolerance
• Heart palpitations
• Sleep disturbance
• Mood changes or anxiety

These symptom clusters often overlap with patterns recognized in other post-infectious syndromes, including Long COVID, reinforcing that prolonged symptoms after infection are not unique to Lyme disease.

How Common Are Persistent Symptoms?

A substantial minority of patients treated for Lyme disease develop ongoing symptoms. Risk appears higher among those with delayed diagnosis, neurologic involvement, severe early illness, co-infections, or a prolonged inflammatory burden.

Both adults and children may be affected, though manifestations differ by age, immune response, and clinical context.

Why Symptoms May Persist After Treatment

Persistent Lyme disease symptoms are likely multifactorial rather than attributable to a single cause. Multiple overlapping contributors may be involved:

• Lingering inflammatory activation
• Immune dysregulation
• Nervous system sensitization
• Autonomic instability
• Unrecognized tick-borne co-infections
• Incomplete pathogen clearance in selected cases (debated)

Different mechanisms may dominate in different patients. For a detailed review of immune, neurologic, autonomic, and debated infection hypotheses, see Persistent Lyme Disease Mechanisms.

PTLDS vs. Chronic Lyme Disease

The term PTLDS is commonly used in research literature to describe persistent symptoms following recommended antibiotic therapy when no alternative diagnosis explains the clinical picture. Chronic Lyme disease is a broader term used by some clinicians and patients to reflect ongoing illness beyond initial treatment.

Terminology differences often reflect differing interpretations of mechanism rather than disagreement about patient suffering. Regardless of which term is used, persistent symptoms warrant careful evaluation and continued clinical engagement.

Clinical Approach to Persistent Symptoms

When symptoms persist, the next step is structured reassessment—not dismissal.

A comprehensive evaluation may include:

• Review of initial diagnosis and treatment timing
• Assessment for co-infections (see Coinfections and Babesia)
• Evaluation of autonomic function (see Autonomic Dysfunction in Lyme Disease)
• Sleep disorder screening
• Inflammatory and immune markers when appropriate
• Neurologic evaluation if indicated

In clinical practice, improvement often resumes when modifiable contributors are identified and addressed systematically. Patients with persistent symptoms may also benefit from a broader discussion of recovery pacing and stabilization strategies in Lyme Disease Recovery.

Frequently Asked Questions

Why do some patients remain ill after antibiotics?
Persistent symptoms may reflect immune dysregulation, autonomic dysfunction, nervous system changes, unrecognized co-infections, or delayed recovery processes. In many cases, more than one contributor is present.

Is PTLDS the same as chronic Lyme disease?
PTLDS is a research-defined framework describing persistent symptoms after recommended therapy. Chronic Lyme disease is a broader term reflecting ongoing illness. The core issue in both is continued symptoms requiring structured reassessment.

Are additional antibiotics always indicated?
No. Treatment decisions should be individualized based on clinical context rather than diagnosis alone. The goal is to identify modifiable contributors, clarify risk factors, and guide next steps with ongoing clinical engagement.

Clinical Perspective

Persistent Lyme disease symptoms are real, measurable, and clinically complex. They warrant careful reassessment rather than attribution to stress, aging, or anxiety alone.

For recovery timelines and long-term outlook, see Lyme Disease Recovery. For the research-defined framework, see Post-Treatment Lyme Disease Syndrome (PTLDS). For mechanisms under investigation, see Persistent Lyme Disease Mechanisms.